As attorneys across the country fight over whether to consolidate litigation over the bladder infection medication Elmiron into a single federal court, a district judge in Pennsylvania has decided that claims seeking medical monitoring over the medication can’t be litigated as a national class action.

U.S. District Judge Wendy Beetlestone of the Eastern District of Pennsylvania granted a motion by Janssen Pharmaceuticals to strike all allegations of a proposed nationwide class action in the case Almond v. Janssen Pharmaceuticals.